Product Information
BRILINTA 90 MG TABLET is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $7.4196 per EA under NDC 00186077760. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jul 20, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Ticagrelor market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
90 mg/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00186077760
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TICAGRELORApproval Type
New Drug (NDA)
FDA Application
NDA022433FDA Approved
7/20/2011
TE Code
AB
On Market Since
8/5/2011
Pharmacological Classes
Price Statistics
The NADAC for BRILINTA 90 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 93.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.4196 per EA |
|---|---|
| All-time high | $7.4294 (May 14, 2025) |
| All-time low | $3.8246 (Dec 18, 2013) |
| 52-week high | $7.4243 |
| 52-week low | $7.4173 |
| Median price | $6.1559 |
| Average price | $6.0161 |
| Largest weekly change | +8.0% (Jan 14, 2015) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BRILINTA 90 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BRILINTA 90 MG TABLET, manufactured by AstraZeneca Pharmaceuticals LP, is $7.4196 per EA (NDC 00186077760), effective Aug 19, 2026.
How has the price of BRILINTA 90 MG TABLET changed over time?
Over the history we have for it, the NADAC for BRILINTA 90 MG TABLET has risen 93.6%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BRILINTA 90 MG TABLET?
Since Nov 28, 2013, the NADAC for BRILINTA 90 MG TABLET has ranged from a low of $3.8246 (Dec 18, 2013) to a high of $7.4294 (May 14, 2025), with a median of $6.1559 per EA.
Are there cheaper alternatives to BRILINTA 90 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TICAGRELOR 90 MG TABLET, is $0.2634 per EA — about 96% below BRILINTA 90 MG TABLET.
Who manufactures BRILINTA 90 MG TABLET?
BRILINTA 90 MG TABLET (NDC 00186077760) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.